Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Aug 29, 2014
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
Dyspnea is a cardinal Respiratory symptom.
According to the ATS dyspnea is the term used to characterize a subjective experience of breathing discomfort, covering qualitatively distinct sensations of varying intensity.
The subjective nature of dyspnea and the high complexity of its determinants explain the often moderate correlations obtained with physiological data. Dyspnea must therefore be measured specifically.
The aim of this study is the cross-sectional and longitudinal psychometric validation of a self-administered dyspnea questionnaire (assessing the impact of dyspnea on activiti...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1) Sample1: COPD GOLD / ATS \> 2 without major co-morbidity
- • Sample 1A: n = 50: group of patients with no change in usual care and no acute event (evaluation of reproducibility)
- • Sample1B: n = 60: patients assessed before and after a qualifying period of pulmonary rehabilitation
- • 2) Sample 2 (n = 30): diffuse interstitial lung diseases Criteria: Pulmonary Fibrosis: Idiopathic or nonspecific interstitial lung diseases (NILD) according to international criteria (ATS), sarcoidosis with parenchymal lesions (old classification stage II and III), and exceptionally alveolar proteinosis.
- • 3) Sample 3 (n = 30) primary or secondary arterial pulmonary hypertension (post embolic .....).
- • 4) Sample4 (n = 30): Adult with Cystic fibrosis.
- • 5) patient with stable Status (no exacerbation for at least one month)
- Exclusion Criteria:
- • 1) Patient under 18 years
- • 2) Inability to fill in questionnaires
- • 3) Other respiratory disease
- • 4) left symptomatic heart failure
- • 5) Obesity with a BMI\> 35 kg/m2
- • 6) Inability to perform PFT (Pulmonary Function Testing)
- • 7) Pregnant or breastfeeding woman
- • 8) Patient unable to consent
- • 9) Lack of social insurance coverage
- • 10) Patient in exclusion period because of another protocol
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Thierry Perez, MD
Study Chair
CHRU de Lille / Hôpital Calmette - France
Nicolas ROCHE, MD, PhD
Principal Investigator
APHP- Hopital Cochin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials